Perpetua Resources in Talks with Glencore, Others for US Antimony Processing
Perpetua Resources is seeking major partners like Glencore and Trafigura to build America's capacity to refine antimony—a vital metal needed for solar panels and defense.
NOTRELOAD AI
Organogenesis Trial Failure Sinks Stock Price
ReNu's second trial for knee pain (OA) missed its main goal, but still showed numerical improvement and function benefits. Organogenesis, confident in the data from all three large studies (1,300+ patients), will ask the FDA to review combined results for approval.
Warner Bros. Discovery Stock: Why the Downgrade?
KeyBanc downgraded WBD stock, citing high valuation after major year-to-date gains and concerns over demanding acquisition terms surrounding CEO David Zaslav's reported $40/share price target.
Goldman Sachs Downgrades Apellis to Sell
Goldman Sachs cut Apellis stock to "Sell," lowering the price target to $18. Risks include slow near-term growth and lower Syfovre sales.
Massive New Tariffs: How Trump’s Latest Duties Hit Drugs, Trucks, and Furniture
President Trump is hitting imports with massive new tariffs starting October 1st, targeting branded drugs (100%), heavy trucks (25%), and furniture.
The 1:1 Chip Plan: How the US Aims to Boost Homegrown Tech
The US 1:1 Chip Plan forces companies to match imported chips with US production (1:1 ratio). If they fail, they face tariffs. This aims to secure national supply chains and stop relying on vulnerable overseas manufacturing, like Taiwan, for essential products.